Navigation Links
Medical Marijuana Player, Cannabis Science Issues Earnings Guidance for 2012 Forecasted at $6,846,000 and Potential Increased to $65,740,000 in 2014 with $0.02 Per Share Positive Earnings
Date:1/4/2012

has identified 20 different medical conditions and 9 different cancers for formulations over the next ten years that would each be an independent profit center for the company.

Dr. Robert Melamede,CEO, said, "Cannabis Science announced intention to have a quarterly conference call to update shareholders and investors in 2012 to track the progress Cannabis Science is making towards its goals. This type of sales forecast communication is a great place to begin to have a more serious conversation between the company and investors both present and future, in regards to the earnings potential for our company in this industry. These projected sales not only translate into shareholder value but these revenues also generate taxes into the economy and create jobs. We acknowledge and understand that these numbers are just a forecast and may be revised over time as we go forward and develop our global sales team."

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipate
'/>"/>

SOURCE Cannabis Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cantel Medical Corp. to Present at the Needham & Company 14th Annual Growth Conference
2. Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions)
3. Acid Attack Victim from Malaysia Restores Her Lost Face with Support of Medical Korea
4. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
5. Medical Alarm Concepts Releases Initial Cut of New Television Commercial Scheduled for January Airing - Provides Investor Update
6. China Sky One Medical Announces Resignation of its Chief Financial Officer
7. FDA Consumer Health Information - FDA Targets Risks From Reused Medical Devices
8. Concord Medical Services Updates Pending Acquisition of Changan Hospital
9. Rochester Medical Director Schnobrich to Retire
10. Winner Medical Appoints BDO China as Independent Auditor
11. Medical Koreas Medical Policy Improvement Project for Foreign Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... SAN DIEGO , Nov. 18, 2014 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that it filed an Investigational New Drug ... Administration (FDA) on Friday, November 14, 2014.  ... development of a patented formulation of the currently ...
(Date:11/18/2014)...   Rio Grande Valley Health Information Exchange (RGV ... Health Science Center at Houston (UTHealth)  School of Public ... selected Wellcentive,s suite of population health management solutions and ... to partner with hospitals and clinics in the region ... uninsured patient populations, initially focusing on the care of ...
(Date:11/18/2014)... , Nov. 17, 2014   Headquartered ... Inc. (OTC: GWPC) is a diversified company.  WholeHEALTH ... convenience of advanced technology and proven expertise of ... business of health and wellness.  WholeHEALTH Products, comprehensive ... doctors, clinics and healthcare centers, and 8 retail ...
Breaking Medicine Technology:HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2
... Lupin Pharmaceuticals, Inc. (LPI) announced today that the ... for the Company,s Abbreviated New Drug Application (ANDA) to ... tablets.  Commercial shipment of the product has commenced. ... mg tablets are the AB-rated generic equivalent of Levaquin, ...
... Therapeutics (NYSE Amex: CXM ) today ... Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los ... lab for the Company’s Generx ASPIRE clinical study. ... consolidation and analysis of SPECT (single-photon emission computed ...
Cached Medicine Technology:Lupin Announces Launch of Generic Levaquin® Tablets 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 3Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 4Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 5Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 6Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 7
(Date:11/18/2014)... Cristcot Inc., a global life ... of specialized drug delivery systems, today announced that ... patent for the technology, which encompasses the company’s ... The patent was awarded to the inventor Jennifer ... assigned to Cristcot Inc. The patented technology, titled ...
(Date:11/18/2014)... Steven Reinberg HealthDay Reporter ... with the abnormal heartbeat known as atrial fibrillation who ... bleeding and blood clots, according to a new study. ... took a blood thinner along with one of these ... (Motrin), naproxen (Aleve) and celecoxib (Celebrex). "If ...
(Date:11/18/2014)... Recently, BellasDress has announced the launch of ... workers and using comfortable fabrics, the new styles of prom ... variety of wonderful holiday gifts in a variety of colors ... prom dresses, and they are created by top designers,” said ... absolutely great addition to our sales team and more than ...
(Date:11/18/2014)... Sometimes at inopportune times during hectic ... like unforeseen error messages or paper jams. This ... find another printer and they don’t know who is ... likely tied up with other mission-critical projects in their ... Electronic Systems, Inc. (ESI) comes in. Since ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. ... a severe abusive head trauma before the age of 5 ... study. In addition, among those who survive severe ... study found. Abusive head trauma includes shaken baby syndrome, ... head injuries, according to background information in the study. ...
Breaking Medicine News(10 mins):Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Some Painkillers Tied to Bleeding Risk in Those With Abnormal Heartbeat 2Health News:85 New Models Of White Prom Dresses From BellasDress.com Online For Sale 2Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4
... Nov. 1 Perrigo Company,(Nasdaq: PRGO ; ... Perrigo,s partner for store brand OTC 20mg Omeprazole ... AstraZeneca (the,manufacturer of Prilosec OTC(R)) involving three Orange ... product. While terms and conditions of the,agreement have ...
... Nov. 1 MannKind Corporation,(Nasdaq: MNKD ), focused on ... that it will present at,the following conferences: * The ... Tuesday November 6, 2007 at 2:20 PM ... New York, NY., * The CIBC 18th Annual ...
... American Diabetes Month, HARRISBURG, Pa., Nov. 1 ... Health Dr. Calvin Johnson today urged,Pennsylvanians to adopt healthy ... diabetes., Diabetes is a chronic disease that affects ... in Pennsylvania., "Diabetes is a serious, public health ...
... Statement by James Wagoner on the $28 ... Nov. 1 The following is a,statement ... increase in abstinence-only,program funding:, Today, we ... committee report includes the full $28 million,increase ...
... InfoLogix, Inc. (Nasdaq:,IFLG), a leading technology provider ... industries, will release its financial results,for the Third ... 8th,2007. Following the press release, President and Chief ... Roberts will host a conference,call with the financial ...
... Edwards Lifesciences,Corporation (NYSE: EW ), a ... cardiovascular disease, is scheduled to participate in the,Southern ... Newport,Beach, California on Wednesday, November 7, 2007. ... Investor,Relations, is scheduled to speak to conference attendees ...
Cached Medicine News:Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 3Health News:Health Secretary Promotes Awareness of Diabetes, Urges Healthy Habits 2Health News:Democrats Cave on Sex Education - Again 2Health News:InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007 2Health News:Edwards Lifesciences to Present at the Southern California Investor Conference 2
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders....
Medicine Products: